Literature DB >> 10050070

Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall.

J E Hungerford1, C D Little.   

Abstract

The assembly of the vessel wall from its cellular and extracellular matrix components is a critical process in the development and maturation of the cardiovascular system. However, fundamental questions concerning the origin of vessel wall cells and the mechanisms that regulate their development and differentiation remain unanswered. The initial step of vessel wall morphogenesis is formation of a primary vascular network, comprised of nascent endothelial cell tubes, via the processes of vasculogenesis and angiogenesis. Subsequently, primordial vascular smooth muscle cells (VSMCs) are recruited to the endothelium to form a multilayered vessel wall. During the course of development and maturation, the VSMC plays diverse roles: it is a biosynthetic, proliferative, and contractile component of the vessel wall. Although the field of vascular development has blossomed in the past decade, the molecules and mechanisms that regulate this developmental pathway are not well defined. The focus of this review is on those facets of VSMC development important for transforming a nascent endothelial tube into a multilayered structure. We discuss the primordial VSMC with particular attention to its purported origins, the components of the extracellular milieu that contribute to its development, and the contribution of embryonic hemodynamics to vessel wall assembly.

Mesh:

Substances:

Year:  1999        PMID: 10050070     DOI: 10.1159/000025622

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  72 in total

Review 1.  Physiology of angiogenesis.

Authors:  H Kurz
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

Review 3.  Vascularization of the developing chick limb bud: role of the TGFbeta signalling pathway.

Authors:  Neil Vargesson
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 4.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

5.  Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.

Authors:  Hanako Kobayashi; Laura M DeBusk; Yael O Babichev; Daniel J Dumont; Pengnian Charles Lin
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 6.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

7.  Cell division cycle 7 is a novel regulator of transforming growth factor-β-induced smooth muscle cell differentiation.

Authors:  Ning Shi; Wei-Bing Xie; Shi-You Chen
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

Review 8.  Vascular smooth muscle cells in cerebral aneurysm pathogenesis.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; Daniel M S Raper; M Sean Mckisic; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-10-10       Impact factor: 6.829

9.  Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice.

Authors:  Jolanta E Pitera; Adrian S Woolf; Nicholas W Gale; George D Yancopoulos; Hai Tao Yuan
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Authors:  Gilles Faury; Mylène Pezet; Russell H Knutsen; Walter A Boyle; Scott P Heximer; Sean E McLean; Robert K Minkes; Kendall J Blumer; Attila Kovacs; Daniel P Kelly; Dean Y Li; Barry Starcher; Robert P Mecham
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.